ALYREF binds to m5C‐modified epidermal growth factor receptor (EGFR) mRNA and promotes cancer growth by stabilizing EGFR mRNA, upregulating EGFR expression and enhancing the STAT3 signaling pathway [71]. This evidence concerns the gene EGFR and cancer.